Results 31 to 40 of about 14,618 (167)

Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study

open access: yesHuman Vaccines & Immunotherapeutics, 2017
This phase IV, single blind study assessed the immunogenicity and safety of India-manufactured purified chick embryo cell rabies vaccine (PCECV), compared with a German-manufactured batch obtained by the same production process.
Gadey Sampath   +6 more
doaj   +1 more source

Comparative effectiveness of liquid and freeze-dried vaccines for oral vaccination of dogs against rabies

open access: yesВетеринария сегодня, 2021
Currently, vaccination is the main measure to combat rabies in domestic and wild animals. Inactivated and live vaccines are used for this purpose. Oral vaccines for wild carnivores contain live attenuated rabies viruses in liquid or freeze-dried form ...
Z. D. Yershebulov   +2 more
doaj   +1 more source

Studies on humoral immunity in dogs after use of rabies inactivated vaccines formulated with Montanide ISA 70 VG and GEL 01 adjuvants

open access: yesВетеринария сегодня, 2020
Despite all the efforts made, the issue of rabies in the world does not lose its relevance. As an acute endemic infection, it poses a considerable danger to both animals and humans.
A. N. Balashov   +5 more
doaj   +1 more source

A thermostable messenger RNA based vaccine against rabies. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2017
Although effective rabies virus vaccines have been existing for decades, each year, rabies virus infections still cause around 50.000 fatalities worldwide. Most of these cases occur in developing countries, where these vaccines are not available.
Lothar Stitz   +8 more
doaj   +1 more source

RABIES SUBUNIT VACCINES

open access: yesJournal of General Virology, 1983
Conclusions The secondary and tertiary structures of the rabies virus spike G protein are important for its ability to induce VN antibodies and confer immunity to the host. For a subunit peptide vaccine to be as effective as the native spike G protein, it would appear that the amino acid sequence comprising the antigenic determinant for VN antibody ...
W H, Wunner   +3 more
openaire   +2 more sources

Anti-rabies vaccines applied in the Russian Federation and perspectives for their improvement

open access: yesВопросы вирусологии, 2022
Rabies is almost ubiquitous (except in certain areas) and poses a significant danger to both animals and humans. Every year around 55,000 people die from this disease worldwide.
A. L. Elakov
doaj   +1 more source

Market mapping and landscape analysis of human rabies biologicals in India

open access: yesIndian Journal of Public Health, 2019
Background: Rabies vaccines and immunoglobulins are lifesaving in humans following animal exposures. These biologicals should continuously be available throughout the year to prevent and eliminate human rabies by 2030. Objectives: The present study aimed
Mysore Kalappa Sudarshan   +2 more
doaj   +1 more source

Rabies vaccines and interferon [PDF]

open access: yesJournal of Hygiene, 1972
SUMMARYSamples of Fermi, Semple, modified Semple, Duck embryo and tissue culture rabies vaccine were inoculated by different routes and in different doses into rabbits, mice and hamsters. The vaccines induced neither detectable interferon nor immediate protection against lethal challenge with CVS rabies virus.Under similar conditions, high but ...
openaire   +2 more sources

ASSESSMENT OF EFFICACY AND SAFETY OF INACTIVATED RABIES VACCINES BASED ON “ARRIAH” STRAIN AND FORMULATED WITH DIFFERENT ADJUVANTS IN CATTLE

open access: yesВетеринария сегодня, 2019
Rabies cases are still reported in various mammal species in the Russian Federation. Wild carnivores contacting with domestic and farm animals and transmitting the pathogen to them are the main source and natural reservoirs of rabies.
A. N. Balashov   +4 more
doaj   +1 more source

A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2018
BACKGROUND:Estimates of current global rabies mortality range from 26,000 to 59,000 deaths per annum. Although pre-exposure prophylaxis using inactivated rabies virus vaccines (IRVs) is effective, it requires two to three doses and is regarded as being ...
Chuan Wang   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy